AmpC β-lactamase-producing Enterobacterales : what a clinician should know

ConclusionsTo date, there is no conclusive evidence about the most appropriate treatment for AmpC-producingEnterobacterales. Carbapenems are often the preferred option, especially for severe infections in which adequate source control is not achieved, but cefepime is also supported by substantial clinical evidences as an effective carbapenem-sparing option.
Source: Infection - Category: Infectious Diseases Source Type: research